Vytorin Class Actions Pile Up Against Merck, Schering

Law360, New York (February 11, 2008, 12:00 AM EST) -- Proposed class action suits are piling up against Merck & Co. and Schering-Plough Corp., claiming the drugmakers broke state consumer protection laws through the sale and marketing of cholesterol-lowering drugs Vytorin and Zetia.

The most recent complaint to launch consumer fraud claims against Merck and Schering-Plough was filed Thursday in the U.S. District Court for the District of New Jersey, a popular venue for many Vytorin suits.

Additionally, the latest suit, National Joint Power Alliance v. Merck & Co. et al., lists almost 50 similar suits...
To view the full article, register now.